Skip to main content
All lobbying filings

PHLOW CORPORATION

Lobbying for PHLOW CORPORATION

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $410,000.00 expenses · posted Jan 20, 2026

Official filing document

 Bills named in this filing 9
  • HR 5304
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
  • S 2587
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
  • HR 4016
    Department of Defense Appropriations Act, 2026
  • S 2572
    Department of Defense Appropriations Act, 2026
  • S 2296
    National Defense Authorization Act for Fiscal Year 2026
  • S 4638
    Promoting Strong Native Families and Children Act
  • S 1784
    MAPS Act
  • S 2062
    RAPID Reserve Act
  • HR 3966
    Think Tank and Nonprofit Foreign Influence Disclosure Act
 Lobbying activity 3
Budget/Appropriations

FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587); FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)

Health Issues

Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)

Manufacturing

Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem